Gene · 7364
Papers2,547
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,547
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Influence of pharmacokinetics-related polymorphisms on asciminib exposure in patients with Japanese chronic myeloid leukemia. | Eur J Clin Pharmacol | 2026 | 41553485 | PubTator, text mining | PubMed |
| "Reconsidering CYP3A4/5 Genotyping for Ticagrelor Safety: Critical Appraisal of a Narrow Genetic Framework". | Clin Cardiol | 2026 | 41459705 | PubTator, text mining | PubMed |
| LABOR-RELATED PAIN MANAGEMENT ACCORDING TO OPIOID RECEPTOR POLYMORPHISMS VARIABILITY. | Acta Endocrinol (Buchar) | 2025 | 41798968 | PubTator, text mining | PubMed |
| Personalized Perioperative Opioid Strategies in Children: Focus on Methadone, Pharmacogenomics and Prevention of Persistent Postoperative Opioid Use. | Children (Basel) | 2025 | 41462800 | PubTator, text mining | PubMed |
| A specific tsRNA in serum from patients with nasopharyngeal carcinoma: 5'tiRNA-32-ValAAC-2 mediates malignance of nasopharyngeal carcinoma cells. | Front Med | 2025 | 41269498 | PubTator, text mining | PubMed |
| Meta-analyses of clozapine, norclozapine levels and their ratio across three genome wide association studies. | Transl Psychiatry | 2025 | 41136382 | PubTator, text mining | PubMed |
| Custom Gene Panel Analysis Identifies Novel Polymorphisms Associated with Clopidogrel Response in Patients Undergoing Percutaneous Coronary Intervention with Stent. | Int J Mol Sci | 2025 | 41097034 | PubTator, text mining | PubMed |
| Prediction of UGT-mediated phase II metabolism via ligand- and structure-based predictive models. | J Cheminform | 2025 | 41094537 | PubTator, text mining | PubMed |
| Changes in the Fraction Metabolized in Children Younger than Four Years; When is Clearance Scaling for the Dominant Elimination Route in Adults Appropriate? | Pharm Res | 2025 | 41087672 | PubTator, text mining | PubMed |
| Prediction of personalized antiseizure medications response based on clinical signatures in epilepsy. | Sci Rep | 2025 | 41006507 | PubTator, text mining | PubMed |
| Integrative RNA-seq and CLIP-seq analysis reveals hnRNP-F regulation of TNFα/NFκB signaling in high-glucose conditions. | Front Physiol | 2025 | 40995516 | PubTator, text mining | PubMed |
| UGT2B7-mediated drug-drug interaction between cannabinoids and hydromorphone. | Drug Metab Dispos | 2025 | 40925219 | PubTator, text mining | PubMed |
| Pharmacogenomics of buprenorphine - a narrative review. | Pharmacogenomics | 2025 | 40908813 | PubTator, text mining | PubMed |
| Recapitulating dengue virus infection with human pluripotent stem cell-derived liver organoids for antiviral screening. | Nat Commun | 2025 | 40877283 | PubTator, text mining | PubMed |
| Genetic Modulation of Silodosin Exposure and Efficacy: The Role of CYP3A4, CYP3A5, and UGT2B7 Polymorphisms in Benign Prostatic Hyperplasia Management. | J Pers Med | 2025 | 40863448 | PubTator, text mining | PubMed |
| Pharmacogenetic exploration of buprenorphine and related metabolites in umbilical cord blood. | Toxicol Rep | 2025 | 40761746 | PubTator, text mining | PubMed |
| Artesunate regulates malignant progression of breast cancer cells via lncRNA TUG1/miR-145-5p/HOXA5 axis. | PLoS One | 2025 | 40758729 | PubTator, text mining | PubMed |
| CYP2B6*6 single nucleotide polymorphism among patients with uncomplicated malaria in Adjumani district, Uganda: Implications on efficacy of artemether-lumefantrine. | PLoS One | 2025 | 40748991 | PubTator, text mining | PubMed |
| A scoping review about smoking, smoking cessation and their effects on anti-tuberculosis agents: insights into drug metabolisms, safety, and effectiveness. | Front Pharmacol | 2025 | 40741006 | PubTator, text mining | PubMed |
| Current Advances in Classification, Prediction and Management of Microvascular Invasion in Hepatocellular Carcinoma. | J Cell Mol Med | 2025 | 40736417 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7364/papers?page=3